May 12, 2015
BioWorld Today. In the heady days when venture capital (VC) was flowing like a waterfall, not-for-profit support of biotech endeavors was considered – by both parties – as a type of gravy, sometimes with the end goal of producing a scientific paper but rarely with a...
May 12, 2015
SAN FRANCISCO – With international dealmaking often a key element of the biopharma asset development adventure, the path to success in Japan took center stage during the first day of Allicense, an annual pilgrimage for the industry’s top business development pros....
May 8, 2015
From licensing to financing to venture trends, deal-making and beyond, Locust Walk Partners has just come back from an incredible 2-days with our biopharma colleagues from across the world. View Article >
Apr 21, 2015
We are pleased to update you about Locust Walk Partners’ leadership role in the upcoming Allicense 2015 Conference. This is the premier event for deal-making, licensing and business development professionals. It will be held on May 5-6, 2015 at the Park...
Mar 10, 2015
RALEIGH, NC — (Marketwired) DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care specialty pharmaceutical company dedicated to providing healthcare professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy...
